Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 42: 1992-1995, 1996;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miida, T.
Right arrow Articles by Okada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miida, T.
Right arrow Articles by Okada, M.

Clinical Chemistry, Vol 42, 1992-1995, Copyright © 1996 by American Association for Clinical Chemistry

Pre beta 1-high-density lipoprotein increases in coronary artery disease

T Miida, Y Nakamura, K Inano, T Matsuto, T Yamaguchi, T Tsuda and M Okada
Department of Laboratory Medicine, Niigata University School of Medicine, Japan. miida@med.niigata-u.ac.jp

Pre beta 1-HDL promotes cholesterol efflux from cell membranes. Its plasma concentration is regulated by lecithin: cholesterol acyltransferase (LCAT). To clarify whether the concentration of pre beta 1-HDL changes in coronary artery disease (CAD), we determined the distribution of apolipoprotein A-I (apoA-I) among HDL subfractions in 20 CAD patients and 20 healthy controls, using nondenaturing two- dimensional gel electrophoresis. We found that CAD patients had significantly higher concentrations of pre beta 1-HDL than the controls [7.6% +/- 3.4% vs 4.6% +/- 2.3% of apoA-I (P < 0.01)]. Even after correcting for apoA-I concentrations, this increase remained significant [87 +/- 37 vs 63 +/- 28 mg/L apoA-I (P < 0.05)]. The mean LCAT concentration was significantly lower (P < 0.05) in CAD patients than in controls. These findings, that pre beta 1-HDL concentrations increase in CAD, strongly suggest that the process of reverse cholesterol transport could be altered in CAD.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
M. Y. Tsai, N. Li, A. R. Sharrett, S. Shea, D. R. Jacobs Jr, R. Tracy, D. Arnett, V. Arends, and W. Post
Associations of Genetic Variants in ATP-Binding Cassette A1 and Cholesteryl Ester Transfer Protein and Differences in Lipoprotein Subclasses in the Multi-Ethnic Study of Atherosclerosis
Clin. Chem., March 1, 2009; 55(3): 481 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
R. P F Dullaart, A. K Groen, G. M Dallinga-Thie, R. de Vries, W. J Sluiter, and A. van Tol
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
Eur. J. Endocrinol., January 1, 2008; 158(1): 53 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
A. Pirillo, P. Uboldi, G. Pappalardo, H. Kuhn, and A. L. Catapano
Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux
Cardiovasc Res, August 1, 2007; 75(3): 566 - 574.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
S. Hirayama, T. Miida, O. Miyazaki, and Y. Aizawa
Pre{beta}1-HDL Concentration Is a Predictor of Carotid Atherosclerosis in Type 2 Diabetic Patients
Diabetes Care, May 1, 2007; 30(5): 1289 - 1291.
[Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
B. F. Asztalos, D. Collins, L. A. Cupples, S. Demissie, K. V. Horvath, H. E. Bloomfield, S. J. Robins, and E. J. Schaefer
Value of High-Density Lipoprotein (HDL) Subpopulations in Predicting Recurrent Cardiovascular Events in the Veterans Affairs HDL Intervention Trial
Arterioscler Thromb Vasc Biol, October 1, 2005; 25(10): 2185 - 2191.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
L. Krimbou, H. Hajj Hassan, S. Blain, S. Rashid, M. Denis, M. Marcil, and J. Genest
Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines
J. Lipid Res., August 1, 2005; 46(8): 1668 - 1677.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
H. Hajj Hassan, S. Blain, B. Boucher, M. Denis, L. Krimbou, and J. Genest
Structural modification of plasma HDL by phospholipids promotes efficient ABCA1-mediated cholesterol release
J. Lipid Res., July 1, 2005; 46(7): 1457 - 1465.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. Suzuki, H. Wada, S. Maeda, K. Saito, S. Minatoguchi, K. Saito, and M. Seishima
Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease
Clin. Chem., January 1, 2005; 51(1): 132 - 137.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
B. Olchawa, B. A. Kingwell, A. Hoang, L. Schneider, O. Miyazaki, P. Nestel, and D. Sviridov
Physical Fitness and Reverse Cholesterol Transport
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1087 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H. Hattori, T. Kujiraoka, T. Egashira, E. Saito, T. Fujioka, S. Takahashi, M. Ito, J. A. Cooper, I. P. Stepanova, M. N. Nanjee, et al.
Association of Coronary Heart Disease with Pre-{beta}-HDL Concentrations in Japanese Men
Clin. Chem., March 1, 2004; 50(3): 589 - 595.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
T. Miida, O. Miyazaki, Y. Nakamura, S. Hirayama, O. Hanyu, I. Fukamachi, and M. Okada
Analytical performance of a sandwich enzyme immunoassay for pre{beta}1-HDL in stabilized plasma
J. Lipid Res., March 1, 2003; 44(3): 645 - 650.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
T. Miida, O. Miyazaki, O. Hanyu, Y. Nakamura, S. Hirayama, I. Narita, F. Gejyo, I. Ei, K. Tasaki, Y. Kohda, et al.
LCAT-Dependent Conversion of Pre{beta}1-HDL into {alpha}-Migrating HDL is Severely Delayed in Hemodialysis Patients
J. Am. Soc. Nephrol., March 1, 2003; 14(3): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
O. Miyazaki, J. Kobayashi, I. Fukamachi, T. Miida, H. Bujo, and Y. Saito
A new sandwich enzyme immunoassay for measurement of plasma pre-{beta}1-HDL levels
J. Lipid Res., December 1, 2000; 41(12): 2083 - 2088.
[Abstract] [Full Text]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
T. Miida, K. Sakai, K. Ozaki, Y. Nakamura, T. Yamaguchi, T. Tsuda, T. Kashiwa, T. Murakami, K. Inano, and M. Okada
Bezafibrate Increases Pre{beta}1-HDL at the Expense of HDL2b in Hypertriglyceridemia
Arterioscler Thromb Vasc Biol, November 1, 2000; 20(11): 2428 - 2433.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. N. Nanjee and E. A. Brinton
Very Small Apolipoprotein A-I-containing Particles from Human Plasma: Isolation and Quantification by High-Performance Size-Exclusion Chromatography
Clin. Chem., February 1, 2000; 46(2): 207 - 223.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Handwerger, G. Datta, B. Richardson, C. M. Schmidt, T. Siddiqi, L. Turzai, and G. M. Anantharamaiah
Pre-beta -HDL stimulates placental lactogen release from human trophoblast cells
Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E384 - E389.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
T. Sasahara, P. Nestel, N. Fidge, and D. Sviridov
Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects
J. Lipid Res., March 1, 1998; 39(3): 544 - 554.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
P. M. O'Connor, B. R. Zysow, S. A. Schoenhaus, B. Y. Ishida, S. T. Kunitake, J. M. Naya-Vigne, P. N. Duchateau, R. F. Redberg, S. J. Spencer, S. Mark, et al.
Prebeta-1 HDL in plasma of normolipidemic individuals: influences of plasma lipoproteins, age, and gender
J. Lipid Res., March 1, 1998; 39(3): 670 - 678.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Association for Clinical Chemistry.